|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01232088 |
|
Date of registration:
|
01/11/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Questionnaire of the Section Perioperative Intensive Care of the European Society of Intensive Care Medicine (ESICM) on Standardized Drug Labelling
|
|
Scientific title:
|
Questionnaire of the Section Perioperative Intensive Care of the European Society of Intensive Care Medicine (ESICM) on Standardized Drug Labelling |
|
Date of first enrolment:
|
November 2010 |
|
Target sample size:
|
482 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01232088 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Germany
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Members of the European Society of Intensive Care Medicine (ESICM)
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Drug Labelling
|
|
Primary Outcome(s)
|
|
The primary objective is to assess if standardized drug syringe labelling is used in European ICUs.
[Time Frame: A period of 90 days.]
|
|
Secondary Outcome(s)
|
|
The second objectives is to assess 1. if standards for drug syringe labelling are similar in European ICUs and 2. if users expect that standardized drug syringe labelling should be delivered by the pharmaceutical industry.
[Time Frame: A period of 90 days]
|
|
Secondary ID(s)
|
|
Standardized Drug Labelling
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|